Matthew Maxwell Donley Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

Matthew Maxwell Donley is Chief Operating Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 695,801 shares of AUPH, which is worth approximately $10.7 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 42,787 shares (Common Stock) at a price of $15.95 per share, resulting in proceeds of $682,452. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 696K

2.25% 3M change

19.13% 12M change

Total Value Held $10.7 Million

Matthew Maxwell Donley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Payment of exercise price or tax liability	$682,452 $15.95 p/Share	42,787 Reduced 5.79%	695,801 Common Stock
Jan 02 2026	BUY Grant, award, or other acquisition	-	54,166 Added 6.87%	734,631 Common Stock
Mar 04 2025	SELL Open market or private sale	$467,208 $7.92 p/Share	58,991 Reduced 7.98%	680,465 Common Stock
Mar 03 2025	SELL Open market or private sale	$527,216 $8.0 p/Share	65,902 Reduced 8.18%	739,456 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	135,567 Added 14.41%	805,358 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	82,781 Added 11.0%	669,791 Common Stock
Mar 06 2024	SELL Open market or private sale	$224,064 $5.51 p/Share	40,665 Reduced 6.51%	584,072 Common Stock

Feb 20 2024	BUY Grant, award, or other acquisition	-	216,666 Added 25.75%	624,737 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	271,134 Added 40.21%	403,141 Common Stock
Nov 21 2022	BUY Open market or private purchase	$46,600 $4.66 p/Share	10,000 Added 26.37%	27,927 Common Stock
Mar 02 2022	SELL Open market or private sale	$36,655 $12.01 p/Share	3,052 Reduced 15.83%	16,224 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	8,500 Added 30.6%	19,276 Common Stock
May 11 2021	BUY Open market or private purchase	$99,693 $10.07 p/Share	9,900 Added 50.0%	9,900 Common Stock

MMD

Matthew Maxwell Donley

Chief Operating Officer

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Value

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH

Account